Tvardi Therapeutics's top three insider shareholders as of May 14, 2026 are Shaheen Wirk (Director, 439.19K shares), Wallace L Jr Hall (Director, 246.76K shares), Derek T Chalmers (President Ceo, 82.62K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Derek T Chalmers | President Ceo | 82,617 | 0 | 09 Sep, 2021 |
| Shaheen Wirk | - | 0 | 439,194 | 02 May, 2025 |
| Martin Vogelbaum | - | 34,251 | 0 | 06 Jun, 2024 |
| Wallace L Jr Hall | - | 0 | 246,756 | 02 May, 2025 |
| Jeffrey L. Ives | - | 16,540 | 0 | 06 Jun, 2024 |
| Moltke Lisa Von | - | 15,251 | 0 | 06 Jun, 2024 |
| Frederique Ph.D. Menzaghi | Chief Scientific Off,Svp Rd | 13,937 | 0 | 05 Feb, 2024 |
| Helen M Boudreau | - | 12,554 | 0 | 06 Jun, 2024 |
| Harrison M Jr Bains | - | 4,787 | 0 | 05 Jun, 2023 |
| Thomas Charles Reilly | Chief Financial Officer | 3,151 | 0 | 04 Mar, 2022 |
| Richard Makara | Vp, Head Of Accting;Controller | 1,132 | 0 | 16 Jun, 2022 |
| Christopher Posner | President And Ceo | 13,109 | 0 | 04 Mar, 2025 |
| Ryan D Maynard | Chief Financial Officer | 668 | 0 | 12 Feb, 2024 |
| Scott Terrillion | Sec'Y; Chief Compliance G.C. | 7,190 | 0 | 04 Mar, 2025 |
| Shaheen Wirk | - | 4,191 | 0 | 17 Apr, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 29 Jan, 2026 | Stephen Paul O'Brien | Employee Stock Option (right to buy) | A | 15,000 | $0.00 | 15,000 | D | A |
| 29 Jan, 2026 | Imran Nizamudin Alibhai | Employee Stock Option (right to buy) | A | 115,000 | $0.00 | 115,000 | D | A |
| 29 Jan, 2026 | Avi Daniel Conn | Employee Stock Option (right to buy) | A | 45,000 | $0.00 | 45,000 | D | A |
| 29 Jan, 2026 | John Saewook M.D. Kauh | Employee Stock Option (right to buy) | A | 45,000 | $0.00 | 45,000 | D | A |
| 16 Dec, 2025 | Imran Nizamudin Alibhai | Employee Stock Option (right to buy) | A | 47,500 | $0.00 | 47,500 | D | A |
| 16 Dec, 2025 | Avi Daniel Conn | Employee Stock Option (right to buy) | A | 17,500 | $0.00 | 17,500 | D | A |
| 16 Dec, 2025 | Stephen Paul O'Brien | Employee Stock Option (right to buy) | A | 4,000 | $0.00 | 4,000 | D | A |
| 16 Dec, 2025 | John Saewook M.D. Kauh | Employee Stock Option (right to buy) | A | 17,500 | $0.00 | 17,500 | D | A |
| 07 Jul, 2025 | Samuel David Tweardy | Common Stock | D | 315,658 | $0.00 | 0 | I | J |
| 07 Jul, 2025 | Samuel David Tweardy | Common Stock | D | 315,658 | $0.00 | 0 | I | J |
| 15 Apr, 2025 | Shaheen Wirk | Common Stock | A | 176,030 | - | 176,030 | I | A |
| 15 Apr, 2025 | Wallace L Jr Hall | Common Stock | A | 44,712 | - | 44,712 | I | A |
| 15 Apr, 2025 | Wallace L Jr Hall | Common Stock | A | 202,044 | - | 202,044 | I | A |
| 15 Apr, 2025 | Shaheen Wirk | Common Stock | A | 263,164 | - | 263,164 | I | A |
| 17 Apr, 2025 | Shaheen Wirk | Stock Option (right to buy) | A | 12,000 | $0.00 | 12,000 | D | A |
| 17 Apr, 2025 | Jeffrey Leroy Larson | Employee Stock Option (right to buy) | A | 10,820 | $0.00 | 10,820 | D | A |
| 17 Apr, 2025 | Cynthia Smith | Stock Option (right to buy) | A | 12,000 | $0.00 | 12,000 | D | A |
| 17 Apr, 2025 | Yixin Chen | Employee Stock Option (right to buy) | A | 7,213 | $0.00 | 7,213 | D | A |
| 17 Apr, 2025 | Sujal Shah | Stock Option (right to buy) | A | 12,000 | $0.00 | 12,000 | D | A |
| 17 Apr, 2025 | Wallace L Jr Hall | Stock Option (right to buy) | A | 12,000 | $0.00 | 12,000 | D | A |